Synthetic Cannabinoid Laboratory Testing Cutoffs and Methods
The following is an explanation of RTL's synthetic cannabinoid confirmation procedures and cutoff levels. The cutoff levels listed below may periodically change.
| 6473: Urine Synthetic Cannabinoid Test Panel— LOD between 0.1 – 0.5 ng/mL for all analytes. |
||
|---|---|---|
| Drug Screening Panel | Methodology | Cutoff Level |
| AKB-48 (and/or metabolites) | LC-MS/MS | Qualitative |
| AM-1248 (and/or metabolites) | LC-MS/MS | Qualitative |
| AM-2201 (and/or metabolites) | LC-MS/MS | Qualitative |
| AM-694 (and/or metabolites) | LC-MS/MS | Qualitative |
| JWH-018 (and/or metabolites) | LC-MS/MS | Qualitative |
| JWH-019 (and/or metabolites) | LC-MS/MS | Qualitative |
| JWH-073 (and/or metabolites) | LC-MS/MS | Qualitative |
| JWH-081 (and/or metabolites) | LC-MS/MS | Qualitative |
| JWH-122 (and/or metabolites) | LC-MS/MS | Qualitative |
| JWH-200 (and/or metabolites) | LC-MS/MS | Qualitative |
| JWH-203 (and/or metabolites) | LC-MS/MS | Qualitative |
| JWH-210 (and/or metabolites) | LC-MS/MS | Qualitative |
| JWH-250 (and/or metabolites) | LC-MS/MS | Qualitative |
| JWH-398 (and/or metabolites) | LC-MS/MS | Qualitative |
| MAM-2201 (and/or metabolites) | LC-MS/MS | Qualitative |
| RCS-4 (and/or metabolites) | LC-MS/MS | Qualitative |
| RCS-8 (and/or metabolites) | LC-MS/MS | Qualitative |
| UR-144 (and/or metabolites) | LC-MS/MS | Qualitative |
| XLR-11 (and/or metabolites) | LC-MS/MS | Qualitative |
| 8474: Premium Urine Synthetic Cannabinoid Test Panel— LOD between 0.1 – 0.5 ng/mL for all analytes. |
||
|---|---|---|
| Drug Screening Panel | Methodology | Cutoff Level |
| 5-fluoro-AB-PINACA (and/or metabolites) | LC-MS/MS | Qualitative |
| 5-fluoro-ADBICA (and/or metabolites) | LC-MS/MS | Qualitative |
| 5-fluoro-ADB-PINACA (and/or metabolites) | LC-MS/MS | Qualitative |
| 5-fluoro-AKB-48 (and/or metabolites) | LC-MS/MS | Qualitative |
| 5-fluoro-AMB (and/or metabolites) | LC-MS/MS | Qualitative |
| 5-fluoro-PB-22 (and/or metabolites) | LC-MS/MS | Qualitative |
| AB-CHMINACA (and/or metabolites) | LC-MS/MS | Qualitative |
| AB-FUBINACA (and/or metabolites) | LC-MS/MS | Qualitative |
| AB-PINACA (and/or metabolites) | LC-MS/MS | Qualitative |
| ADBICA (and/or metabolites) | LC-MS/MS | Qualitative |
| ADB-PINACA (and/or metabolites) | LC-MS/MS | Qualitative |
| AKB-48 (and/or metabolites) | LC-MS/MS | Qualitative |
| AM-1248 (and/or metabolites) | LC-MS/MS | Qualitative |
| AM-2201 (and/or metabolites) | LC-MS/MS | Qualitative |
| AM-694 (and/or metabolites) | LC-MS/MS | Qualitative |
| BB-22 (and/or metabolites) | LC-MS/MS | Qualitative |
| FDU-PB-22 (and/or metabolites) | LC-MS/MS | Qualitative |
| FUB-144 (and/or metabolites) | LC-MS/MS | Qualitative |
| FUB-AMB (and/or metabolites) | LC-MS/MS | Qualitative |
| FUB-PB-22 (and/or metabolites) | LC-MS/MS | Qualitative |
| JWH-018 (and/or metabolites) | LC-MS/MS | Qualitative |
| JWH-019 (and/or metabolites) | LC-MS/MS | Qualitative |
| JWH-073 (and/or metabolites) | LC-MS/MS | Qualitative |
| JWH-081 (and/or metabolites) | LC-MS/MS | Qualitative |
| JWH-122 (and/or metabolites) | LC-MS/MS | Qualitative |
| JWH-200 (and/or metabolites) | LC-MS/MS | Qualitative |
| JWH-203 (and/or metabolites) | LC-MS/MS | Qualitative |
| JWH-210 (and/or metabolites) | LC-MS/MS | Qualitative |
| JWH-250 (and/or metabolites) | LC-MS/MS | Qualitative |
| JWH-398 (and/or metabolites) | LC-MS/MS | Qualitative |
| MAM-2201 (and/or metabolites) | LC-MS/MS | Qualitative |
| PB-22 (and/or metabolites) | LC-MS/MS | Qualitative |
| RCS-4 (and/or metabolites) | LC-MS/MS | Qualitative |
| RCS-8 (and/or metabolites) | LC-MS/MS | Qualitative |
| THJ-2201 (and/or metabolites) | LC-MS/MS | Qualitative |
| UR-144 (and/or metabolites) | LC-MS/MS | Qualitative |
| XLR-11 (and/or metabolites) | LC-MS/MS | Qualitative |
| F25: Oral Fluid Synthetic Cannabinoid Test Panel | ||
|---|---|---|
| Drug Screening Panel | Methodology | Cutoff Level |
| AKB-48 | LC/MS/MS | .25 ng/mL |
| AM-1248 | LC/MS/MS | .25 ng/mL |
| AM-2201 | LC/MS/MS | .25 ng/mL |
| AM-694 | LC/MS/MS | .25 ng/mL |
| JWH-018 | LC/MS/MS | .25 ng/mL |
| JWH-019 | LC/MS/MS | .25 ng/mL |
| JWH-073 | LC/MS/MS | .25 ng/mL |
| JWH-081 | LC/MS/MS | .25 ng/mL |
| JWH-122 | LC/MS/MS | .25 ng/mL |
| JWH-200 | LC/MS/MS | .25 ng/mL |
| JWH-203 | LC/MS/MS | .25 ng/mL |
| JWH-210 | LC/MS/MS | .25 ng/mL |
| JWH-250 | LC/MS/MS | .25 ng/mL |
| JWH-398 | LC/MS/MS | .25 ng/mL |
| MAM-2201 | LC/MS/MS | .25 ng/mL |
| RCS-4 | LC/MS/MS | .25 ng/mL |
| RCS-8 | LC/MS/MS | .25 ng/mL |
| UR-144 | LC/MS/MS | Qualitative |
| XLR-11 | LC/MS/MS | .25 ng/mL |
How to read your Toxicology Report »
Non-Clinical Test Requisition Form video »